YERVOY® (ipilimumab) is used for treatment of a specific type of skin cancer, known as Melanoma in children over the age of 12 years and adults.
Treatment of metastatic melanomas and those which cannot be removed by surgery, in individuals above 12 years of age. It prevent recurrence of melanomas after the primary lesion and associated lymph nodes have been removed surgically.
It is not known if YERVOY is safe and effective in children less than 12 years of age.
- Non-Small Cell Lung Cancer,
- Metastatic Melanoma,
- Renal Cell Carcinoma,
- Squamous Cell Carcinoma of the Head & Neck,
- Liver Cancer (Hepatocellular Carcinoma),
- Bladder Cancer (Urothelial Carcinoma),
- Colorectal cancer specific types
- Classic Hodgkin Lymphoma
Patients receiving Yervoy therapy must be closely monitored as the drug has many serious and life-threatening side effects.
- Intestinal colitis
- Liver failure
- Skin reactions
- Neural problems
- Hormonal problems
- Vision problems
- Aches in stomach
- Loose stools
- Muscle weakness
- Vision problems
- Breathing problems
- Kidney and Liver problems
- Hormonal disorders
Warnings and Precautions
- You must always inform your doctor about your past and present drug allergies, other substance allergies before consuming these drugs. Drug allergies to both active ingredients and inactive agents are common.
- Before using these drugs, inform your doctor or pharmacist regarding relevant medical history, especially that related to bleeding tendency, Kidney diseases and liver ailments. Also, inform about all the drugs you are presently taking.
- Patients with heart ailments and high blood pressure must be closely monitored while taking these drugs.
- Pregnancy, breastfeeding and trying to conceive are contraindicated while taking this drug.